Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03623373
Brief Title: Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

First Submitted : July 26, 2018
First Submitted that Met QC Criteria : August 7, 2018
First Posted : August 9, 2018

Last Update Submitted that Met QC Criteria : November 4, 2019
Last Update Posted : November 6, 2019